News + Filings Transactions
|
Raffin Thomas A.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/12/2023 | Akoya Biosciences, Inc. | AKYA | Purchase | Common Stock | 20k | $5.00 | $100k | Thomas A. Raffin Living Trust dated March 29, 2017 | 06/12/2023 |
06/12/2023 | Akoya Biosciences, Inc. | AKYA | Purchase | Common Stock | 196.6k | $5.00 | $983.1k | See Footnote | 06/12/2023 |
06/12/2023 | Akoya Biosciences, Inc. | AKYA | Purchase | Common Stock | 1.8M | $5.00 | $9M | See Footnote | 06/12/2023 |
06/01/2023 | Akoya Biosciences, Inc. | AKYA | Grant | Stock Option (Right to Buy) | 56.3k | $5.70 | $321k | | 06/01/2023 |
05/10/2023 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 3.3k | $3.42 | $11.4k | | 05/10/2023 |
08/25/2022 | LUMOS PHARMA, INC. | NLNK | Purchase | Common Stock | 1.2k | $8.46 | $9.7k | | 08/25/2022 |
06/01/2022 | Akoya Biosciences, Inc. | AKYA | Grant | Stock Option (Right to Buy | 30.5k | $11.24 | $343.4k | | 06/01/2022 |
05/05/2022 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 3.4k | $8.18 | $28.1k | | 05/05/2022 |
05/21/2021 | Akoya Biosciences, Inc. | AKYA | Grant | Stock Option (Right to Buy | 16.9k | $21.95 | $370.1k | | 05/21/2021 |
05/20/2021 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 367 | $0.00 | $0 | | 05/20/2021 |
05/20/2021 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 2.9k | $10.36 | $30.1k | | 05/20/2021 |
04/03/2020 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 709 | $0.00 | $0 | | 04/03/2020 |
04/03/2020 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 5.7k | $7.78 | $44.2k | | 04/03/2020 |
05/10/2019 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 25k | $1.69 | $42.2k | | 05/10/2019 |
05/23/2018 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 27.8k | $5.33 | $148.1k | | 05/23/2018 |
04/30/2015 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 2k | $0.00 | $0 | | 04/30/2015 |
04/30/2015 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 3.6k | $44.60 | $162.5k | | 04/30/2015 |
04/07/2015 | LUMOS PHARMA, INC. | NLNK | Sale | Common Stock | 800 | $53.18 | $42.5k | | 04/07/2015 |
04/07/2015 | LUMOS PHARMA, INC. | NLNK | Sale | Common Stock | 10k | $54.32 | $544.5k | | 04/07/2015 |
04/07/2015 | LUMOS PHARMA, INC. | NLNK | Sale | Common Stock | 9.9k | $55.03 | $543.1k | | 04/07/2015 |
04/07/2015 | LUMOS PHARMA, INC. | NLNK | Exercise | Stock Option (Right to Buy) | 7.1k | $2.10 | $15k | | 04/07/2015 |
04/07/2015 | LUMOS PHARMA, INC. | NLNK | Exercise | Stock Option (Right to Buy) | 7.1k | $10.02 | $71.6k | | 04/07/2015 |
04/07/2015 | LUMOS PHARMA, INC. | NLNK | Exercise | Stock Option (Right to Buy) | 3.2k | $1.96 | $6.3k | | 04/07/2015 |
05/01/2014 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 2.9k | $0.00 | $0 | | 05/01/2014 |
05/01/2014 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 8.8k | $21.23 | $187.5k | | 05/01/2014 |
01/02/2014 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 3k | $0.00 | $0 | | 01/02/2014 |
05/09/2013 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 12k | $14.71 | $176.5k | | 05/09/2013 |
|